Related to the association observed between anti-CCP2 and RA-ILD, ACPAs are specific for RA and correspond to a subset of RA that is distinct from RA ACPA-negative in terms of pathogenesis, disease prognosis, and response to therapy. This evidence concerns the gene AGBL2 and rheumatoid arthritis.